Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 925350, 13 pages
http://dx.doi.org/10.1155/2014/925350
Review Article

FOXO Transcription Factors: Their Clinical Significance and Regulation

1Department of Implantology, School of Stomatology, Jilin University, Changchun 130021, China
2Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

Received 4 November 2013; Accepted 17 January 2014; Published 3 April 2014

Academic Editor: Eric W. Lam

Copyright © 2014 Yu Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Obsil and V. Obsilova, “Structure/function relationships underlying regulation of FOXO transcription factors,” Oncogene, vol. 27, no. 16, pp. 2263–2275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. K. E. Van Der Vos and P. J. Coffer, “The extending network of FOXO transcriptional target genes,” Antioxidants and Redox Signaling, vol. 14, no. 4, pp. 579–592, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Hosaka, W. H. Biggs III, D. Tieu et al., “Disruption of Forkhead transcription factor (FOXO) family members in mice reveals their functional diversification,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2975–2980, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Lin, J. D. Hron, and S. L. Peng, “Regulation of NF-κB, Th activation, and autoinflammation by the Forkhead transcription factor Foxo3a,” Immunity, vol. 21, no. 2, pp. 203–213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. V. M. Renault, V. A. Rafalski, A. A. Morgan et al., “FoxO3 regulates neural stem cell homeostasis,” Cell Stem Cell, vol. 5, no. 5, pp. 527–539, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Zhou, Q. Cao, Y. Peng et al., “FoxO4 inhibits NF-κB and protects mice against colonic injury and inflammation,” Gastroenterology, vol. 137, no. 4, pp. 1403–1414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. A. Salih, A. J. Rashid, D. Colas et al., “FoxO6 regulates memory consolidation and synaptic function,” Genes & Development, vol. 26, no. 24, pp. 2780–2801, 2012. View at Publisher · View at Google Scholar
  8. M. M. Brent, R. Anand, and R. Marmorstein, “Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification,” Structure, vol. 16, no. 9, pp. 1407–1416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Brunet, F. Kanai, J. Stehn et al., “14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport,” Journal of Cell Biology, vol. 156, no. 5, pp. 817–828, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Obsilova, J. Vecer, P. Herman et al., “14-3-3 protein interacts with nuclear localization sequence of Forkhead transcription factor FoxO4,” Biochemistry, vol. 44, no. 34, pp. 11608–11617, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M.-T. Rached, A. Kode, L. Xu et al., “FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts,” Cell Metabolism, vol. 11, no. 2, pp. 147–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Alikhani, Z. Alikhani, and D. T. Graves, “FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis,” The Journal of Biological Chemistry, vol. 280, no. 13, pp. 12096–12102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Alikhani, S. Roy, and D. T. Graves, “FOXO1 plays an essential role in apoptosis of retinal pericytes,” Molecular Vision, vol. 16, pp. 408–415, 2010. View at Google Scholar · View at Scopus
  14. J. Alblowi, R. A. Kayal, M. Siqueria et al., “High levels of tumor necrosis factor-α contribute to accelerated loss of cartilage in diabetic fracture healing,” The American Journal of Pathology, vol. 175, no. 4, pp. 1574–1585, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Alikhani, C. M. MacLellan, M. Raptis, S. Vora, P. C. Trackman, and D. T. Graves, “Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor,” The American Journal of Physiology: Cell Physiology, vol. 292, no. 2, pp. C850–C856, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. W. J. Bakker, M. Blázquez-Domingo, A. Kolbus et al., “FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1,” Journal of Cell Biology, vol. 164, no. 2, pp. 175–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. D. L. Allen and T. G. Unterman, “Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors,” The American Journal of Physiology: Cell Physiology, vol. 292, no. 1, pp. C188–C199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Al-Masri, M. Krishnamurthy, J. Li et al., “Effect of Forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas,” Diabetologia, vol. 53, no. 4, pp. 699–711, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Ponugoti, F. Xu, C. Zhang et al., “FOXO1 promotes wound healing through the up-regulation of TGF-beta1 and prevention of oxidative stress,” The Journal of Cell Biology, vol. 203, no. 2, pp. 327–343, 2013. View at Publisher · View at Google Scholar
  20. E. Ambrogini, M. Almeida, M. Martin-Millan et al., “FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice,” Cell Metabolism, vol. 11, no. 2, pp. 136–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Lu, Y. Zhai, Q. Cheng et al., “The Akt-FoxO3a-manganese superoxide dismutase pathway is involved in the regulation of oxidative stress in diabetic nephropathy,” Experimental Physiology, vol. 98, no. 4, pp. 934–945, 2013. View at Publisher · View at Google Scholar
  22. C. B. Chiribau, L. Cheng, I. C. Cucoranu, Y.-S. Yu, R. E. Clempus, and D. Sorescu, “FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts,” The Journal of Biological Chemistry, vol. 283, no. 13, pp. 8211–8217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Speckmann, P. L. Walter, L. Alili et al., “Selenoprotein P expression is controlled through interaction of the coactivator PGC-1α with FoxO1a and hepatocyte nuclear factor 42α transcription factors,” Hepatology, vol. 48, no. 6, pp. 1998–2006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-P. Hsu, P. Zhai, T. Yamamoto et al., “Silent information regulator 1 protects the heart from ischemia/reperfusion,” Circulation, vol. 122, no. 21, pp. 2170–2182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. G. Ni, K. Berenji, N. Wang et al., “Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling,” Circulation, vol. 114, no. 11, pp. 1159–1168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Ito, H. Daitoku, and A. Fukamizu, “FOXO1 increases pro-inflammatory gene expression by inducing C/EBPβ in TNF-α-treated adipocytes,” Biochemical and Biophysical Research Communications, vol. 378, no. 2, pp. 290–295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Su, G. M. Coudriet, H. K. Dae et al., “FOXO1 links insulin resistance to proinflammatory cytokine IL-1β production in macrophages,” Diabetes, vol. 58, no. 11, pp. 2624–2633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Fan, H. Morinaga, J. J. Kim et al., “FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages,” The EMBO Journal, vol. 29, no. 24, pp. 4223–4236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Behl, P. Krothapalli, T. Desta, S. Roy, and D. T. Graves, “FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats,” Diabetes, vol. 58, no. 4, pp. 917–925, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Brown, H. Wang, J. Suttles, D. T. Graves, and M. Martin, “Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates toll-like receptor 4-mediated inflammatory response via FoxO1,” The Journal of Biological Chemistry, vol. 286, no. 52, pp. 44295–44305, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Salminen, J. Huuskonen, J. Ojala, A. Kauppinen, K. Kaarniranta, and T. Suuronen, “Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging,” Ageing Research Reviews, vol. 7, no. 2, pp. 83–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Maiese, J. Hou, Z. Z. Chong, and Y. C. Shang, “A fork in the path: developing therapeutic inroads with foxO proteins,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 3, pp. 119–129, 2009. View at Google Scholar · View at Scopus
  33. E. L. Greer and A. Brunet, “FOXO transcription factors at the interface between longevity and tumor suppression,” Oncogene, vol. 24, no. 50, pp. 7410–7425, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. N. H. Uhlenhaut and M. Treier, “Forkhead transcription factors in ovarian function,” Reproduction, vol. 142, no. 4, pp. 489–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. W. Edmonds, J. K. Prasain, D. Dorand et al., “Insulin/FOXO signaling regulates ovarian prostaglandins critical for reproduction,” Developmental Cell, vol. 19, no. 6, pp. 858–871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. S. Lalmansingh, S. Karmakar, Y. Jin, and A. K. Nagaich, “Multiple modes of chromatin remodeling by Forkhead box proteins,” Biochimica et Biophysica Acta: Gene Regulatory Mechanisms, vol. 1819, no. 7, pp. 707–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Tikhanovich, J. Cox, and S. A. Weinman, “Forkhead box class O transcription factors in liver function and disease,” Journal of Gastroenterology and Hepatology, vol. 28, supplement S1, pp. 125–131, 2013. View at Publisher · View at Google Scholar
  38. J. A. Engelman, “Targeting PI3K signalling in cancer: opportunities, challenges and limitations,” Nature Reviews Cancer, vol. 9, no. 8, pp. 550–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. Q. Xie, J. Chen, and Z. Yuan, “Post-translational regulation of FOXO,” Acta Biochimica et Biophysica Sinica, vol. 44, no. 11, pp. 897–901, 2012. View at Publisher · View at Google Scholar
  40. G. Rena, Y. L. Woods, A. R. Prescott et al., “Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion,” The EMBO Journal, vol. 21, no. 9, pp. 2263–2271, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Zhao, L. Gan, H. Pan et al., “Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms,” Biochemical Journal, vol. 378, no. 3, pp. 839–849, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Kobayashi, Y. Furukawa-Hibi, C. Chen et al., “SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress,” International Journal of Molecular Medicine, vol. 16, no. 2, pp. 237–243, 2005. View at Google Scholar · View at Scopus
  43. D. R. Calnan and A. Brunet, “The FoxO code,” Oncogene, vol. 27, no. 16, pp. 2276–2288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Daitoku, M. Hatta, H. Matsuzaki et al., “Silent information regulator 2 potentiates Foxo 1-mediated transcription through its deacetylase activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 27, pp. 10042–10047, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. T. B. Dansen, L. M. M. Smits, M. H. van Triest et al., “Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity,” Nature Chemical Biology, vol. 5, no. 9, pp. 664–672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. V. D. Longo and B. K. Kennedy, “Sirtuins in aging and age-related disease,” Cell, vol. 126, no. 2, pp. 257–268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Aoki, H. Jiang, and P. K. Vogt, “Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 37, pp. 13613–13617, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Huang, K. M. Regan, F. Wang et al., “Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 5, pp. 1649–1654, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. A. B. Brenkman, P. L. J. de Keizer, N. J. F. van den Broek, A. G. Jochemsen, and B. M. T. Burgering, “Mdm2 induces mono-ubiquitination of FOXO4,” PLoS ONE, vol. 3, no. 7, Article ID e2819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. A. van der Horst, L. G. J. Tertoolen, L. M. M. De Vries-Smits, R. A. Frye, R. H. Medema, and B. M. T. Burgering, “FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2SIRT1,” The Journal of Biological Chemistry, vol. 279, no. 28, pp. 28873–28879, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. A. van der Horst, A. M. M. de Vries-Smits, A. B. Brenkman et al., “FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP,” Nature Cell Biology, vol. 8, no. 10, pp. 1064–1073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Putker, T. Madl, H. R. Vos et al., “Redox-dependent control of FOXO/DAF-16 by transportin-1,” Molecular Cell, vol. 49, no. 4, pp. 730–742, 2013. View at Publisher · View at Google Scholar
  53. S. Ramaswamy, N. Nakamura, I. Sansal, L. Bergeron, and W. R. Sellers, “A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR,” Cancer Cell, vol. 2, no. 1, pp. 81–91, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Yamamura, L. L. Wei, K.-I. Inoue, H. Ida, and Y. Ito, “RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells,” The Journal of Biological Chemistry, vol. 281, no. 8, pp. 5267–5276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Städeli, R. Hoffmans, and K. Basler, “Transcription under the control of nuclear Arm/β-catenin,” Current Biology, vol. 16, no. 10, pp. R378–R385, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. J. E. Dominy and P. Puigserver, “Nuclear FoxO1 inflames insulin resistance,” The EMBO Journal, vol. 29, no. 24, pp. 4068–4069, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. R. S. Hundal, K. F. Petersen, A. B. Mayerson et al., “Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes,” The Journal of Clinical Investigation, vol. 109, no. 10, pp. 1321–1326, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. X. Li and G. R. Stark, “NFκB-dependent signaling pathways,” Experimental Hematology, vol. 30, no. 4, pp. 285–296, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Miao, Y. Zhang, Z. Lu, L. Yu, and L. Gan, “FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxis,” Molecular Endocrinology, vol. 26, no. 3, pp. 423–437, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Harant, S. A. Eldershaw, and I. J. Lindley, “Human macrophage inflammatory protein-3alpha/CCL20/LARC/Exodus/SCYA20 is transcriptionally upregulated by tumor necrosis factor-alpha via a non-standard NF-kappaB site,” FEBS Letters, vol. 509, no. 3, pp. 439–445, 2001. View at Publisher · View at Google Scholar
  61. C. Postic, R. Dentin, and J. Girard, “Role of the liver in the control of carbohydrate and lipid homeostasis,” Diabetes and Metabolism, vol. 30, no. 5, pp. 398–408, 2004. View at Google Scholar · View at Scopus
  62. J. C. Yoon, P. Puigserver, G. Chen et al., “Control of hepatic gluconeogenesis through the transcriptional coaotivator PGC-1,” Nature, vol. 413, no. 6852, pp. 131–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. W. Zhang, S. Patil, B. Chauhan et al., “FoxO1 regulates multiple metabolic pathways in the liver effects on gluconeogenic, glycolytic, and lipogenic gene expression,” The Journal of Biological Chemistry, vol. 281, no. 15, pp. 10105–10117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Matsumoto, A. Pocai, L. Rossetti, R. A. DePinho, and D. Accili, “Impaired regulation of hepatic glucose production in mice lacking the Forkhead transcription factor FOXO1 in Liver,” Cell Metabolism, vol. 6, no. 3, pp. 208–216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Altomonte, A. Richter, S. Harbaran et al., “Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice,” The American Journal of Physiology: Endocrinology and Metabolism, vol. 285, no. 4, pp. E718–E728, 2003. View at Google Scholar · View at Scopus
  66. P. Puigserver, J. Rhee, J. Donovan et al., “Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction,” Nature, vol. 423, no. 6939, pp. 550–555, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Nakae, W. H. Biggs III, T. Kitamura et al., “Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding Forkhead transcription factor Foxo1,” Nature Genetics, vol. 32, no. 2, pp. 245–253, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Kitamura, J. Nakae, Y. Kitamura et al., “The Forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth,” The Journal of Clinical Investigation, vol. 110, no. 12, pp. 1839–1847, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. M.-T. Rached, A. Kode, B. C. Silva et al., “FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice,” The Journal of Clinical Investigation, vol. 120, no. 1, pp. 357–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. R. A. Haeusler, S. Han, and D. Accili, “Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia,” The Journal of Biological Chemistry, vol. 285, no. 35, pp. 26861–26868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Alblowi, C. Tian, M. F. Siqueira et al., “Chemokine expression is upregulated in chondrocytes in diabetic fracture healing,” Bone, vol. 53, no. 1, pp. 294–300, 2013. View at Publisher · View at Google Scholar
  72. R. A. Kayal, M. Siqueira, J. Alblowi et al., “TNF-α mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1,” Journal of Bone and Mineral Research, vol. 25, no. 7, pp. 1604–1615, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. M. F. Siqueira, J. Li, L. Chehab et al., “Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of Forkhead box O1 (FOXO1),” Diabetologia, vol. 53, no. 2, pp. 378–388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Desta, J. Li, T. Chino, and D. T. Graves, “Altered fibroblast proliferation and apoptosis in diabetic gingival wounds,” Journal of Dental Research, vol. 89, no. 6, pp. 609–614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Yan, D. E. Vatner, S.-J. Kim et al., “Autophagy in chronically ischemic myocardium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 13807–13812, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Shimomura, F. Terasaki, T. Hayashi, Y. Kitaura, T. Isomura, and H. Suma, “Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy,” Japanese Circulation Journal, vol. 65, no. 11, pp. 965–968, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. U. Pfeifer, J. Fohr, W. Wilhelm, and J. Dammrich, “Short-term inhibition of cardiac cellular autophagy by isoproterenol,” Journal of Molecular and Cellular Cardiology, vol. 19, no. 12, pp. 1179–1184, 1987. View at Google Scholar · View at Scopus
  78. A. Sengupta, J. D. Molkentin, and K. E. Yutzey, “FoxO transcription factors promote autophagy in cardiomyocytes,” The Journal of Biological Chemistry, vol. 284, no. 41, pp. 28319–28331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. N. Hariharan, Y. Ikeda, C. Hong et al., “Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart,” PloS ONE, vol. 8, no. 1, Article ID e51632, 2013. View at Publisher · View at Google Scholar
  80. V. Modur, R. Nagarajan, B. M. Evers, and J. Milbrandt, “FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression: implications for PTEN mutation in prostate cancer,” The Journal of Biological Chemistry, vol. 277, no. 49, pp. 47928–47937, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. I. Ciechomska, B. Pyrzynska, P. Kazmierczak, and B. Kaminska, “Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells,” Oncogene, vol. 22, no. 48, pp. 7617–7627, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Pratap, J. B. Lian, A. Javed et al., “Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone,” Cancer and Metastasis Reviews, vol. 25, no. 4, pp. 589–600, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Zhang, Y. Pan, L. Zheng et al., “FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion,” Cancer Research, vol. 71, no. 9, pp. 3257–3267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Goto, M. Takano, J. Hirata, and H. Tsuda, “The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers,” British Journal of Cancer, vol. 98, no. 6, pp. 1068–1075, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. J.-H. Paik, R. Kollipara, G. Chu et al., “FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis,” Cell, vol. 128, no. 2, pp. 309–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. Z. Tothova, R. Kollipara, B. J. Huntly et al., “FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress,” Cell, vol. 128, no. 2, pp. 325–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Buteau and D. Accili, “Regulation of pancreatic β-cell function by the Forkhead protein FoxO1,” Diabetes, Obesity and Metabolism, vol. 9, no. 2, pp. 140–146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. B. Ponugoti, G. Dong, and D. T. Graves, “Role of Forkhead transcription factors in diabetes-induced oxidative stress,” Experimental Diabetes Research, vol. 2012, Article ID 939751, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Fabre, F. Carrette, J. Chen et al., “FOXO1 regulates L-selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase,” Journal of Immunology, vol. 181, no. 5, pp. 2980–2989, 2008. View at Google Scholar · View at Scopus
  90. Y. M. Kerdiles, D. R. Beisner, R. Tinoco et al., “Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor,” Nature Immunology, vol. 10, no. 2, pp. 176–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. W. Ouyang, O. Beckett, R. A. Flavell, and M. O. Li, “An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance,” Immunity, vol. 30, no. 3, pp. 358–371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. H. S. Dengler, G. V. Baracho, S. A. Omori et al., “Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation,” Nature Immunology, vol. 9, no. 12, pp. 1388–1398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. M. M. Tejera, E. H. Kim, J. A. Sullivan et al., “FoxO1 controls effector-to-memory transition and maintenance of functional CD8 T cell memory,” Journal of Immunology, vol. 191, no. 1, pp. 187–199, 2013. View at Publisher · View at Google Scholar
  94. Y. M. Kerdiles, E. L. Stone, D. L. Beisner et al., “Foxo transcription factors control regulatory T cell development and function,” Immunity, vol. 33, no. 6, pp. 890–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. M. F. Siqueira, S. Flowers, R. Bhattacharya et al., “FOXO1 modulates osteoblast differentiation,” Bone, vol. 48, no. 5, pp. 1043–1051, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. C. C. Teixeira, Y. Liu, L. M. Thant, J. Pang, G. Palmer, and M. Alikhani, “Foxo1, a novel regulator of osteoblast differentiation and skeletogenesis,” The Journal of Biological Chemistry, vol. 285, no. 40, pp. 31055–31065, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Iyer, E. Ambrogini, S. M. Bartell et al., “FOXOs attenuate bone formation by suppressing Wnt signaling,” The Journal of Clinical Investigation, vol. 123, no. 8, pp. 3409–3419, 2013. View at Publisher · View at Google Scholar
  98. Y. Behl, M. Siqueira, J. Ortiz et al., “Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen,” Journal of Immunology, vol. 181, no. 12, pp. 8711–8718, 2008. View at Google Scholar · View at Scopus
  99. M. R. Abid, K. Yano, S. Guo et al., “Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia,” The Journal of Biological Chemistry, vol. 280, no. 33, pp. 29864–29873, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. H.-Y. Lee, J.-W. Chung, S.-W. Youn et al., “Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia,” Circulation Research, vol. 100, no. 3, pp. 372–380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Skurk, Y. Izumiya, H. Maatz et al., “The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling,” The Journal of Biological Chemistry, vol. 280, no. 21, pp. 20814–20823, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Essafi, S. Fernández De Mattos, Y. A. M. Hassen et al., “Direct transcriptional regulation of bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells,” Oncogene, vol. 24, no. 14, pp. 2317–2329, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. A. Sunters, S. Fernández de Mattos, M. Stahl et al., “FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines,” The Journal of Biological Chemistry, vol. 278, no. 50, pp. 49795–49805, 2003. View at Publisher · View at Google Scholar · View at Scopus
  104. O. Delpuech, B. Griffiths, P. East et al., “Induction of Mxi1-SRα by FOX03a contributes to repression of Myc-dependent gene expression,” Molecular and Cellular Biology, vol. 27, no. 13, pp. 4917–4930, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. R. C.-Y. Hui, A. R. Gomes, D. Constantinidou et al., “The Forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression,” Molecular and Cellular Biology, vol. 28, no. 19, pp. 5886–5898, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. D. Marinkovic, X. Zhang, S. Yalcin et al., “Foxo3 is required for the regulation of oxidative stress in erythropoiesis,” The Journal of Clinical Investigation, vol. 117, no. 8, pp. 2133–2144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. D. Anastasiou, G. Poulogiannis, J. M. Asara et al., “Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses,” Science, vol. 334, no. 6060, pp. 1278–1283, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. K. Miyamoto, “FoxO3a is essential for the maintenance of hematopoietic stem cell pool,” Rinshō Ketsueki, vol. 49, no. 3, pp. 141–146, 2008. View at Google Scholar · View at Scopus
  109. H. You, M. Pellegrini, K. Tsuchihara et al., “FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal,” Journal of Experimental Medicine, vol. 203, no. 7, pp. 1657–1663, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. A. S. Dejean, D. R. Beisner, I. L. Ch'en et al., “Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells,” Nature Immunology, vol. 10, no. 5, pp. 504–513, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. I. Yusuf, X. Zhu, M. G. Kharas, J. Chen, and D. A. Fruman, “Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors,” Blood, vol. 104, no. 3, pp. 784–787, 2004. View at Publisher · View at Google Scholar · View at Scopus
  112. Y. Harada, Y. Harada, C. Elly et al., “Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells,” The Journal of Experimental Medicine, vol. 207, no. 7, pp. 1381–1391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. S.-I. Yamagishi, K. Fukami, S. Ueda, and S. Okuda, “Molecular mechanisms of diabetic nephropathy and its therapeutic intervention,” Current Drug Targets, vol. 8, no. 8, pp. 952–959, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. J. M. Forbes, M. E. Cooper, M. D. Oldfield, and M. C. Thomas, “Role of advanced glycation end products in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, no. 3, pp. S254–S258, 2003. View at Google Scholar · View at Scopus
  115. P. Y. Chuang, Y. Dai, R. Liu et al., “Alteration of Forkhead box o (FOXO4) acetylation mediates apoptosis of podocytes in diabetes mellitus,” PLoS ONE, vol. 6, no. 8, Article ID e23566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. A. Mukhopadhyay, S. W. Oh, and H. A. Tissenbaum, “Worming pathways to and from DAF-16/FOXO,” Experimental Gerontology, vol. 41, no. 10, pp. 928–934, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. H. Li, J. Liang, D. H. Castrillon, R. A. DePinho, E. N. Olson, and Z.-P. Liu, “FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription,” Molecular and Cellular Biology, vol. 27, no. 7, pp. 2676–2686, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. L. Xiang-qiang, T. Shan-hong, Z. Zhi-yong, and J. Hai-feng, “Expression and clinical significance of FOX04 in colorectal cancer,” Chinese Journal of Cellular and Molecular Immunology, vol. 27, no. 9, pp. 969–971, 2011. View at Google Scholar · View at Scopus
  119. H. Yang, R. Zhao, H.-Y. Yang, and M.-H. Lee, “Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity,” Oncogene, vol. 24, no. 11, pp. 1924–1935, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. M.-J. Lee, G.-R. Yu, H.-J. Yoo et al., “ANXA8 down-regulation by EGF-FOXO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma,” Gastroenterology, vol. 137, no. 3, pp. 1138.e9–1150.e9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. L. De La Torre-Ubieta, B. Gaudillière, Y. Yang et al., “A FOXO-Pak1 transcriptional pathway controls neuronal polarity,” Genes and Development, vol. 24, no. 8, pp. 799–813, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. D. H. Kim, G. Perdomo, T. Zhang et al., “FoxO6 integrates insulin signaling with gluconeogenesis in the liver,” Diabetes, vol. 60, no. 11, pp. 2763–2774, 2011. View at Publisher · View at Google Scholar · View at Scopus